R&D

Showing 11 posts of 146 posts found.

abpi

UK research cannot rest on its laurels, warns ABPI

October 21, 2011
Medical Communications, Research and Development ABPI, NHS, R&D

The ABPI has warned that the UK must continue to attract investment for research, or risk being superseded by emerging …

Shanghai China flag

Betting big on research in China

September 13, 2011
Manufacturing and Production, Research and Development China, R&D

For eighteen out of the last twenty centuries, China has stood as the world’s most innovative and largest economy – …

‘This R&D Malarkey, it’s broken, isn’t it?’

March 9, 2011
Research and Development R&D, Sandwich, research productivity

Pharmaceutical industry leaders are increasingly admitting that the very low productivity of its R&D pipelines is unsustainable – but no …

Lilly HQ

Lilly hails progress of new R&D approaches

February 16, 2011
Research and Development, Sales and Marketing Chorus, Mirror Portfolio, R&D, lilly

Lilly says two of its experimental approaches to re-designing R&D are beginning to pay off.Like all of its peers, the …

R&D productivity worse than previously reported

February 15, 2011
Manufacturing and Production, Research and Development, Sales and Marketing BIO, BMT, FDA, R&D

A new analysis of pharma’s R&D pipelines suggests the overall success rate for drugs moving from clinical trials to FDA …

Pfizer's R&D site in Sandwich, Kent

Pfizer to close UK R&D site

February 1, 2011
Research and Development Kent, Pfizer, R&D, Sandwich, closure

Pfizer has announced that it is to close its UK research site at Sandwich in Kent, with the loss of …

Money trap

Drug development: where’s the added investment value?

February 18, 2010
Research and Development CRO, Les Rose, R&D, biotech, funding

Venture capital is a curious business. The global financial crisis which we are slowly emerging from has exposed some rather …

Get the best from your R&D team

December 6, 2006
Business Services, Research and Development R&D, recruitment

One of the key drivers of much of the recent merger and acquisition activity within the pharmaceutical industry is the …

R&D Scoreboard poor gauge of pharma investment in the UK

November 8, 2005
Research and Development AstraZeneca, GSK, Pfizer, R&D, R&D scoreboard

 The R&D Scoreboard is fundamentally flawed as a measure of R&D investment in the UK and pharmaceutical companies are continuing …

Pharma continues to invest in UK research and development

October 24, 2005
Sales and Marketing Pfizer, R&D

 UK pharma and biotech companies increased R&D investment by 4% in the last year, according to the latest government figures.The …

Commercial and R&D: reinventing the relationship

October 17, 2003
Research and Development R&D, commercial

Traditionally, pharma companies have been run as research-based organisations relying on well-integrated internal R&D capabilities to feed their commercial pipelines …

The Gateway to Local Adoption Series

Latest content